Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG

被引:316
作者
Carter, Stephen F.
Scholl, Michael
Almkvist, Ove [2 ]
Wall, Anders [3 ]
Engler, Henry [3 ,4 ]
Langstrom, Bengt [5 ,6 ]
Nordberg, Agneta [1 ,7 ]
机构
[1] Karolinska Inst, Div Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, S-14186 Stockholm, Sweden
[2] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden
[3] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden
[4] Uruguayan Ctr Mol Imaging CUDIM, Montevideo, Uruguay
[5] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden
[6] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Neuropsychopharmacol Unit, London, England
[7] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Alzheimer disease; mild cognitive impairment; PET; astrocytosis; amyloid; monoamine oxidase B; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; MONOAMINE-OXIDASE-B; HUMAN-BRAIN; MAO-B; CLINICAL PROGRESSION; MICROGLIA; INHIBITOR; DIAGNOSIS; HEALTH;
D O I
10.2967/jnumed.110.087031
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Astrocytes colocalize with fibrillar amyloid-beta (A beta) plaques in postmortem Alzheimer disease (AD) brain tissue. It is therefore of great interest to develop a PET tracer for visualizing astrocytes in vivo, enabling the study of the regional distribution of both astrocytes and fibrillar A beta. A multitracer PET investigation was conducted for patients with mild cognitive impairment (MCI), patients with mild AD, and healthy controls using C-11-deuterium-L-deprenyl (C-11-DED) to measure monoamine oxidase B located in astrocytes. Along with C-11-DED PET, C-11-Pittsburgh compound B (C-11-PIB; fibrillar A beta deposition), F-18-FDG (glucose metabolism), T1 MRI, cerebrospinal fluid, and neuropsychologic data were acquired from the patients. Methods: C-11-DED PET was performed in MCI patients (n = 8; mean age 6 SD, 62.6 +/- 7.5 y; mean Mini Mental State Examination, 27.5 +/- 2.1), AD patients (n = 7; mean age, 65.1 +/- 6.3 y; mean Mini Mental State Examination, 24.4 +/- 5.7), and healthy age-matched controls (n = 14; mean age, 64.7 +/- 3.6 y). A modified reference Patlak model, with cerebellar gray matter as a reference, was chosen for kinetic analysis of the C-11-DED data. C-11-DED data from 20 to 60 min were analyzed using a digital brain atlas. Mean regional F-18-FDG uptake and C-11-PIB retention were calculated for each patient, with cerebellar gray matter as a reference. Results: ANOVA analysis of the regional C-11-DED binding data revealed a significant group effect in the bilateral frontal and bilateral parietal cortices related to increased binding in the MCI patients. All patients, except 3 with MCI, showed high C-11-PIB retention. Increased C-11-DED binding in most cortical and subcortical regions was observed in MCI C-11-PIB+ patients relative to controls, MCI C-11-PIB (negative) patients, and AD patients. No regional correlations were found between the 3 PET tracers. Conclusion: Increased C-11-DED binding throughout the brain of the MCI C-11-PIB+ patients potentially suggests that astrocytosis is an early phenomenon in AD development.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 39 条
  • [11] Age-related increases in brain monoamine oxidase B in living healthy human subjects
    Fowler, JS
    Volkow, ND
    Wang, GJ
    Logan, J
    Pappas, N
    Shea, C
    Macgregor, R
    [J]. NEUROBIOLOGY OF AGING, 1997, 18 (04) : 431 - 435
  • [12] MONOAMINE OXIDASE-B (MAO-B) INHIBITOR THERAPY IN PARKINSONS-DISEASE - THE DEGREE AND REVERSIBILITY OF HUMAN BRAIN MAO-B INHIBITION BY RO 19 6327
    FOWLER, JS
    VOLKOW, ND
    LOGAN, J
    SCHLYER, DJ
    MACGREGOR, RR
    WANG, GJ
    WOLF, AP
    PAPPAS, N
    ALEXOFF, D
    SHEA, C
    GATLEY, SJ
    DORFLINGER, E
    YOO, K
    MORAWSKY, L
    FAZZINI, E
    [J]. NEUROLOGY, 1993, 43 (10) : 1984 - 1992
  • [13] MAPPING HUMAN-BRAIN MONOAMINE OXIDASE-A AND OXIDASE-B WITH C-11 LABELED SUICIDE INACTIVATORS AND PET
    FOWLER, JS
    MACGREGOR, RR
    WOLF, AP
    ARNETT, CD
    DEWEY, SL
    SCHLYER, D
    CHRISTMAN, D
    LOGAN, J
    SMITH, M
    SACHS, H
    AQUILONIUS, SM
    BJURLING, P
    HALLDIN, C
    HARTVIG, P
    LEENDERS, KL
    LUNDQVIST, H
    ORELAND, L
    STALNACKE, CG
    LANGSTROM, B
    [J]. SCIENCE, 1987, 235 (4787) : 481 - 485
  • [14] Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography
    Gulyas, Balazs
    Pavlova, Elena
    Kasa, Peter
    Gulya, Karoly
    Bakota, Lidia
    Varszegi, Szilvia
    Keller, Eva
    Horvath, Monika Csilla
    Nag, Sangram
    Hermecz, Istvan
    Magyar, Kalman
    Halldin, Christer
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2011, 58 (01) : 60 - 68
  • [15] Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
    Hammers, A
    Allom, R
    Koepp, MJ
    Free, SL
    Myers, R
    Lemieux, L
    Mitchell, TN
    Brooks, DJ
    Duncan, JS
    [J]. HUMAN BRAIN MAPPING, 2003, 19 (04) : 224 - 247
  • [16] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    Hardy, J
    Selkoe, DJ
    [J]. SCIENCE, 2002, 297 (5580) : 353 - 356
  • [17] Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301
    Hirvonen, J.
    Kailajarvi, M.
    Haltia, T.
    Koskimies, S.
    Nagren, K.
    Virsu, P.
    Oikonen, V.
    Sipilae, H.
    Ruokoniemi, P.
    Virtanen, K.
    Scheinin, M.
    Rinne, J. O.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) : 506 - 512
  • [18] Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
    Ikonomovic, Milos D.
    Klunk, William E.
    Abrahamson, Eric E.
    Mathis, Chester A.
    Price, Julie C.
    Tsopelas, Nicholas D.
    Lopresti, Brian J.
    Ziolko, Scott
    Bi, Wenzhu
    Paljug, William R.
    Debnath, Manik L.
    Hope, Caroline E.
    Isanski, Barbara A.
    Hamilton, Ronald L.
    DeKosky, Steven T.
    [J]. BRAIN, 2008, 131 : 1630 - 1645
  • [19] Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET
    Johansson, Anders
    Engler, Henry
    Blomquist, Gunnar
    Scott, Berit
    Wall, Anders
    Aquilonius, Sten-Magnus
    Langstrom, Bengt
    Askmark, Hakan
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 255 (1-2) : 17 - 22
  • [20] CEREBRAL PERFUSION IMAGING IN ALZHEIMERS-DISEASE - USE OF SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY AND IOFETAMINE HYDROCHLORIDE-I-123
    JOHNSON, KA
    MUELLER, ST
    WALSHE, TM
    ENGLISH, RJ
    HOLMAN, BL
    [J]. ARCHIVES OF NEUROLOGY, 1987, 44 (02) : 165 - 168